Breakthrough Stem Cell Treatments For Children With Autism

Current therapies for autism being done at PRMEDICA attempt to reverse these abnormalities and address the neurological and metabolic effects of the disorder. The rationale behind treating autism with umbilical cord tissue-derived mesenchymal stem cells is that autism, and its degree of severity, is correlated with inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous (IV) administration of ethically-sourced umbilical cord MSCs harvested from Vitro Biopharma (the parent company of Fitore Nutrition) in the United States, has been shown in multiple early-grade clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate or in some cases completely eliminate symptoms of autism.

PRMEDICA first begins the treatment with an IV combination of stem cells and exosomes to promote connectivity in the brain, assist in nerve regeneration, reduce brain inflammation and regulate abnormal immune responses. The subsequent steps of the procedure are focused on increasing the quality of life improving general metabolic functions. This is done through a combination of therapies that increase the amount of cell oxygen intake, fulfill the body´s requirements of vitamins, minerals, and antioxidants, and cleanse the blood-flow of calcium plaque, heavy metal buildup, oxidative stress and free radical levels.

Mesenchymal stem cells are immune system privileged therefore cell rejection is not an issue.

• MSC's have the best anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration.
• Mesenchymal stem cells can be administered multiple times over the course of days.
• No need to collect stem cells from the patient’s hip bone or fat under anesthesia, which (especially for small children), can be an unpleasant ordeal.

The neuroprotective properties of mesenchymal stem cells and MSC exosomes inhibit neuroinflammation, increase neurogenesis, enhance neurite remodeling, increase cell proliferation and improve neurological function.

• 50 million United States and FDA Registered Facility-sourced (Vitro Biopharma) umbilical cord (mesenchymal stem cells) MSC´s by IV infusion.
• 8-10 Myers Cocktails.

The neuroprotective properties of mesenchymal stem cells and MSC exosomes inhibit neuroinflammation, increase neurogenesis, enhance neurite remodeling, increase cell proliferation and improve neurological function. The new and advance protocol for treating Autism as follows:

• Low dose mesenchymal stem cell IV infusion. 1 million stem cells per kilogram of body weight, or less.
• 3 x 5ml. IV infusions of exosomes (15 billion exosome). Each IV infusion of 5ml exosomes administered every 15 days depending on the doctor´s instructions.
• For severe symptoms, an additional intrathecal injection of 3ml exosomes is performed by an anesthesiologist in an operating room.
• 8 – 10 ozone autohemotherapy sessions.
• 8 – 10 hyperbaric oxygen therapies (1.5 hours per session).
• 8 – 10 Myer´s cocktails.
• 8 – 10 Chelation therapies.
• Stem cell booster implant.

Complete the form below and we´ll rush information to you about the success of exosomes and stem cell therapy for people suffering from Autism. Patients will receive 20% off their treatment until the 30th of November. We also have advanced protocols for the treatment of Alzheimer's Disease, Parkinson's Disease, and Dementia. Contact us today if this treatment is of interest to you, your family, and your loved ones.